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METHODOLOGY ARTICLE

Open Access

Population-based rare variant detection via
pooled exome or custom hybridization capture
with or without individual indexing
Enrique Ramos1, Benjamin T Levinson1, Sara Chasnoff1, Andrew Hughes1, Andrew L Young1, Katherine Thornton1,
Allie Li2, Francesco LM Vallania1, Michael Province1 and Todd E Druley1,3,4*

Abstract
Background: Rare genetic variation in the human population is a major source of pathophysiological variability
and has been implicated in a host of complex phenotypes and diseases. Finding disease-related genes harboring
disparate functional rare variants requires sequencing of many individuals across many genomic regions and
comparing against unaffected cohorts. However, despite persistent declines in sequencing costs, population-based
rare variant detection across large genomic target regions remains cost prohibitive for most investigators. In
addition, DNA samples are often precious and hybridization methods typically require large amounts of input DNA.
Pooled sample DNA sequencing is a cost and time-efficient strategy for surveying populations of individuals for rare
variants. We set out to 1) create a scalable, multiplexing method for custom capture with or without individual DNA
indexing that was amenable to low amounts of input DNA and 2) expand the functionality of the SPLINTER
algorithm for calling substitutions, insertions and deletions across either candidate genes or the entire exome by
integrating the variant calling algorithm with the dynamic programming aligner, Novoalign.
Results: We report methodology for pooled hybridization capture with pre-enrichment, indexed multiplexing of up
to 48 individuals or non-indexed pooled sequencing of up to 92 individuals with as little as 70 ng of DNA per
person. Modified solid phase reversible immobilization bead purification strategies enable no sample transfers from
sonication in 96-well plates through adapter ligation, resulting in 50% less library preparation reagent consumption.
Custom Y-shaped adapters containing novel 7 base pair index sequences with a Hamming distance of ≥2 were
directly ligated onto fragmented source DNA eliminating the need for PCR to incorporate indexes, and was
followed by a custom blocking strategy using a single oligonucleotide regardless of index sequence. These results
were obtained aligning raw reads against the entire genome using Novoalign followed by variant calling of
non-indexed pools using SPLINTER or SAMtools for indexed samples. With these pipelines, we find sensitivity and
specificity of 99.4% and 99.7% for pooled exome sequencing. Sensitivity, and to a lesser degree specificity, proved
to be a function of coverage. For rare variants (≤2% minor allele frequency), we achieved sensitivity and specificity
of ≥94.9% and ≥99.99% for custom capture of 2.5 Mb in multiplexed libraries of 22–48 individuals with only
≥5-fold coverage/chromosome, but these parameters improved to ≥98.7 and 100% with 20-fold coverage/
chromosome.
(Continued on next page)
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Conclusions: This highly scalable methodology enables accurate rare variant detection, with or without individual
DNA sample indexing, while reducing the amount of required source DNA and total costs through less
hybridization reagent consumption, multi-sample sonication in a standard PCR plate, multiplexed pre-enrichment
pooling with a single hybridization and lesser sequencing coverage required to obtain high sensitivity.
Keywords: Rare variants, Genomics, Exome, Hybridization capture, Multiplexed capture, Indexed capture, SPLINTER

Background
Evidence that rare genetic variation modulates common,
complex phenotypes and diseases continues to mount
[1-4], which has spurred efforts to study larger affected
cohorts in order to have adequate statistical power for
causative rare variant identification. However, despite the
ever-declining costs of sequencing, recent efforts to sequence entire exomes [5-7] or use genome-wide array
data to inform candidate gene selection [1] result in a
huge expansion of the number of candidate genes to be
surveyed. Yet, sequencing a large number of candidate
loci in thousands of individuals remains largely cost prohibitive in terms of capture costs, sequencing costs and
bioinformatic capability for the standard investigator. To
address this limitation, we previously pioneered efforts in
cost-effective, population-based rare variant detection
using pooled DNA sequencing methods and the pooled
sequencing analysis tools, SNPseeker and SPLINTER
[8,9]. While highly accurate and computationally efficient,
these tools were designed for discreet target regions (e.g.
<500 kb) and their aligners were inadequate for larger
reference sequences.
In parallel, commercial capture-by-hybridization products have proven to be powerful tools for the custom
enrichment of coding and/or other genomic regions of
interest. These protocols are designed to hybridize complimentary oligonucleotide probes to the target regions
of interest from a single DNA sample in a single incubation step. The efficacy of these methods to identify novel,
deleterious monogenetic variants in Mendelian disorders
has been reported in a variety of studies [4-7]. Newer
products offer multiplexing of up to eight individuals in a
single exome hybridization capture but require individual
preparation of DNA libraries prior to hybridization, which
increases DNA handling and reagent cost. Despite modest
levels of available multiplexing, performing custom or
exome hybridization capture on a large population of
individuals followed by sequencing and data analysis
remains a costly and time consuming proposition for
most investigators.
To address these limitations, a variety of library preparation and multiplexing strategies, with and without
individual indexing, have been put forth in the literature [10-18]. There are a variety of things to consider
when selecting a pooled hybridization method. We have

considered these technical aspects when designing and
comparing our method: is indexing used or anonymous
pooling; how large of a pool can be created; if indexing is
used, is possible cross-contamination of indexes reported
and quantified; are duplicate reads accounted for in the
data analysis; what percentage of raw data is on or neartarget; how large of a capture is performed; how uniform
is the resultant data for each individual within the pooled
or multiplexed sample; and, finally, how accurate are the
results. Cost is certainly an important parameter for consideration, but is difficult to quantify given the rapidly
changing environment and access to certain platforms
at different institutions. While not all of these studies
report their findings in each of these categories, we find
that our strategy compares favorably or surpasses reported
findings in many instances (detailed further in the Discussion), yet remains cost-effective and practical for
smaller labs requiring manual sample preparation.
Obtaining accurate results from pools without individual
indexing, even modestly sized pools of 20–50 individuals,
can be quite challenging [10,11]. We have previously
shown that the SPLINTER algorithm is highly sensitive
for rare variant detection in pools of up to 500 individuals [9]. Previously, SPLINTER had only been used
with PCR-amplified target sequences of modest total size.
Here, we have expanded the capability of SPLINTER
to larger target sequences acquired through solution
hybridization capture without compromising its accuracy
in a small pool of five exomes and in a larger pool of
92 individuals across 2.5 Mb. Our indexing strategy is
compatible with low amounts of input DNA, less than
100 ng, which is often a limiting resource in large
populations of DNA samples. This is primarily possible
by eliminating all DNA sample transfers, including
post-sonication, prior to hybridization and integrating
a size-selection solid phase reversible immobilization
(SPRI) bead cleanup strategy similar to that described
by Fisher [19]. We employ a series of unique indexes
that are effectively blocked using a single, novel blocking
oligonucleotide incorporating deoxyinosine, rather than
perfectly complimentary or degenerate sequences. This
reduces cost and library complexity. We validated our
methodology by comparing sequencing results to individual genotyping data and find an excellent concordance
between pooled custom or exome hybridization capture
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results for common and rare variant detection. Overall,
we believe this methodology provides a robust, scalable,
accurate option for rare variant detection in complex
phenotypes.

Results and discussion
Individual exome analysis

Initial reports of SureSelect [20] exome sequencing analysis used the program MAQ [21] to align short reads to
the human genome [5,7]. Subsequent steps involved calling substitutions with MAQ and then using Cross_match
[22] for INDEL calling. However, we have previously
demonstrated that MAQ is inadequate for the analysis of
pooled DNA samples [9], and wanted to use the same
alignment tool for both the individual and pooled sample
to minimize differences in variant calling due to variable
alignments. Our first experiment was to compare Affymetrix 6.0 genome-wide array (GWA), individual exome
and pooled exome sequencing from the same five individuals (Additional file 1: Table S1, rows 1–5). Because the
aligner included in the SPLINTER software package was
not designed for large reference sequences, we elected to
use Novoalign for sequence alignment, which performs
gapped alignments enabling simultaneous calling of substitutions and INDELs. We then used SAMtools [23] for
variant calling. We called all variants with ≥5-fold coverage/chromosome (≥10-fold/base position) to demonstrate
a high degree of accuracy at low coverage thresholds,
which facilitates costs savings through reduced sequencing. There was an average of 16,040 total variants
called/person (range 15,824-16,186) and an average
of 1,194 novel variants per person (range 1,073-1,284).
Additional file 1: Table S2 lists sequencing metrics for
each individual.
To validate our individual and pooled sequencing
results, we compared common positions between the
exome sequencing and the GWA, as well as individual
genotyping by Sequenom MassArray [24] for 127 positions, including six novel variants, not on the GWA and
falling within genes of potential biological relevance for
the phenotype under investigation within these individuals. Additional file 1: Figure S2A shows a highly reproducible average sensitivity across all five individuals of
96.9% (range 96.3 – 97.3%). Similarly, Additional file 1:
Figure S2B shows a highly reproducible average specificity of 99.8% (range 99.7 – 99.8). Additional file 1: Table
S3 lists results from individual genotyping compared to
individual and pooled exome sequencing. We found that
95.3% were identical, including all novel variants, between individual exome sequence analysis and genotyping.
These data demonstrate that our bioinformatic pipeline
is not only computationally efficient, but also accurate
even with as little as 5-fold coverage/chromosome.
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Pooled exome analysis

After establishing the accuracy of the single exome analysis, we focused on adapting the Novoalign alignment
pipeline for integration with SPLINTER. To test this, we
prepared a pool of normalized DNA from the same five
individuals previously analyzed separately (pool size of
10 alleles). Systematic sequencing platform errors were
modeled and subtracted from raw data as previously published [9, Additional file 1: Figure S1]. Additional file 1:
Figure S2A shows that our pooled sequencing sensitivity
slightly outperformed our individual exome sensitivity,
demonstrating an accuracy of 99.4%. This improvement
is likely due to the fact that we only considered called
variants from pooled sequencing with ≥20-fold coverage
based on prior results [9], supporting the idea that we
could improve our individual exome variant calling
sensitivity by restricting to positions with higher coverage thresholds. Figure 1 shows the correlation for substitution minor allele frequencies (MAF) between the
individual and pooled sequencing to be R2 = 0.97, suggesting uniform capture and representation of the
minor alleles in the pooled sample. Positions deviating
from the idealized correlation are shown to be deficient
in sequencing coverage in either the single or pooled
sequencing (Additional file 1: Figure S3). Additional
file 1: Figure S2B shows the specificity of the pooled
hybridization capture to be 99.7%. Considering the nonarray positions individually genotyped by Sequenom
(Additional file 1: Table S3), we find a correlation of

Figure 1 Allele frequency by individual versus pooled exome
sequencing. Correlation plot comparing a total of 2,937 positions
found in the Agilent SureSelect hybridization exome capture and
Affymetrix 6.0 array between individual versus pooled exomes.
Difference in size between the spheres represents the relative
number of variant positions with the same minor allele frequency.
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R2 = 0.81 between SPLINTER and either SAMtools or
Sequenom. The lower correlation is due to seven no-calls
by SPLINTER. For SPLINTER to call a variant, the
complimentary base change must be noted on each
strand to a degree that passes the defined P-value cutoff.
In these cases, one strand failed to achieve adequate
sequencing that surpasses the P-value threshold, thus
leaving these positions uncalled.
Pooled custom hybridization capture

For this experiment, we analyzed non-indexed pooled
sequencing results of 464 candidate genes (Additional
file 1: Table S4) from 92 individuals enrolled in the Long
Life Family Study (LLFS, see Methods for details). Each
individual had Illumina HumanOmni 2.5-8 Beadchip
GWA data available for comparison. Using filtering criteria listed in Methods under “Pooled sequencing analysis of 92 individuals at 464 genes”, we identified 875
substitutions for comparison. Of these, 499 were called
polymorphic at some frequency by SPLINTER or the
GWA, yielding a concordance of R2 = 0.984 (Figure 2).
There were 116 rare substitutions within this dataset
(MAF <5%) and 104 (89.7%) were called within 1% of the
array-based MAF by SPLINTER, 2 were not called and
the remaining 10 were called within 2% of the arraybased MAF. At least some of the discrepancies were
likely due to GWA errors. When considering only the
396 substitutions called homozygous wild type by GWA,
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we find a specificity of 94.9%. However, if we exclude
positions from consideration that have an INDEL within
15 bp called by sequencing in at least one individual,
25 positions are excluded and our specificity improves
to 97.8%. This suggests false negative array errors due to
nearby INDELs that adversely affect probe binding.
For INDEL analysis in this experiment, we aggregated
the INDEL calls from the individual sequencing of all
92 individuals and compared against SPLINTER’s calls.
When restricting our analysis to 1 bp INDELs, SPLINTER
identified 90% (99 of 110) with a concordance of R2 = 0.73
(Additional file 1: Figure S4). For rare INDEL calling
(MAF <5%), SPLINTER detected 83.3% (45 of 54). While
these results are good overall, the dropoff in concordance
from substitution detection to that of INDELs further
highlights the difficulty of accurate INDEL detection.
Thus, we have expanded the prior capability of the
SPLINTER algorithm for use with any size target sequence. SPLINTER was previously shown to outperform
other algorithms, such as CRISP [18], for rare variant
and INDEL detection in anonymous pools of up to 500
individuals [9], but the aligner was not efficient for survey of large reference sequences. Recent reports of anonymous pooling from smaller pools of 2–50 individuals
[10,11,18] use hybridization capture on smaller capture
targets (up to 1.6 Mb). Both studies removed duplicate
reads prior to alignment and report 48-55% of data on
target (compared to our 42-47%). However, Harakalova

Figure 2 Pooled capture SNV minor allele frequency correlation. Correlation plot comparing a total of 499 positions that overlapped
between the custom hybridization targeted regions and the Illumina Omni-2.5-8 genome wide SNV array with at least one variant called by the
array or pooled analysis. Of these 499 positions, 477 (95.6%) had at least one variant allele call by both SPLINTER and the array, 20 were called as
SNVs by SPLINTER but not by the array, and 2 were called as SNVs by the array but not by SPLINTER.
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failed to validate any called variant predicted at less than
25% MAF in pools of 20 [11]. Day-Williams found that
solution hybridization capture outperformed PCR or
array-based hybridization methods and report a sensitivity and specificity of 98.2% and 97.0% for a smaller
pool of 20 individuals using MAQ v0.1.7 for alignment
and Syzygy for SNV calling with no analysis of INDELs.
Bansal and colleagues surveyed 594 kb in pools of 20
and report a sensitivity of 93% at 30-fold coverage for
substitutions and a positive predictive value of 87% for
INDELs compared to a false positive rate of 0.9%. In
comparison, we find a sensitivity of >96% at 20-fold
coverage in a pool of four captures of 22–24 each.
Indexed custom hybridization capture

While pooling samples without indexing is cost-effective
for surveying sequence variation between populations,
it’s obviously advantageous to directly link a called variant to a particular individual within the multiplex. A variety of studies have introduced barcodes or indexing into
multiplexes ranging in size from 5–96 individuals for
target sizes of 0.14-3.3 Mb [12-18]. These reports start
with anywhere from 0.2-3 μg of DNA per individual.
Rohland and Reich created libraries with as little as
200 ng of DNA/person but report 50% sample loss from
their blunt end adapter ligation strategy and therefore
recommend using ≥500 ng of DNA/pp [16]. We have also
adopted a blunt-end adapter ligation strategy incorporating Y-shaped adapters and have not seen significant sample loss, which has enabled comparable outcomes from
libraries starting with 70 ng/pp up through 350 ng/pp. In
addition, we present a novel, simplified adapter blocking
strategy using deoxyinosines along with a custom set of
96 indexes (Additional file 1: Table S5).
In this experiment, we analyzed sequencing data from
the same 464 candidate genes (Additional file 1: Table S4)
in 280 LLFS individuals and incorporated individual
DNA indexing prior to pre-hybridization multiplexing.
To test pre-enrichment multiplexing of various sizes, we
created nine separate multiplexes of 22 (n = 1), 23 (n = 2),
24 (n = 1), 30 (n = 2), 32 (n = 1) and 48 (n = 2) and using
70–350 ng DNA/pp. Additional file 1: Table S1 lists how
the multiplexes were then combined for three separate
lanes of HiSeq 2000 sequencing with 92–96 individuals
in each lane. We first studied the single lane of 92 individuals from four multiplexes of 22–24 individuals each
(rows 7–10), and found that >96% of raw data contained
an identifiable index and that >97% of the individuals
(2 samples failed) were within a 2.3-fold difference in
raw read counts (Additional file 1: Figure S5). Also, individuals did not cluster predominantly within distinct
captures (compare the distribution of symbols within
each dataset in Additional file 1: Figure S5), suggesting
that the library preparation and hybridization was highly
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uniform and did not introduce bias in the sequencing
output. After excluding the two failed samples, aligning
unique reads and removing PCR duplicates, 81.9% (±1.8)
of total reads per person were aligned in a trend that
closely followed the number of raw reads per sample
(Additional file 1: Figure S5, cyan symbols). We
observed 13.4% (±1.9) PCR duplication (Additional file 1:
Figure S6, red symbols). After removing these duplicates,
41.8% (±1.1) of the aligned bases were on or within
250 bp (“on or near target”) of our targeted intervals
and 33.4% (±0.9) were directly on targeted regions
(Additional file 1: Figure S6, blue and green symbols
respectively), demonstrating that the percent duplication
and capture efficiency were uniform between all samples
and the four independent multiplexes. In addition, we
demonstrated that our candidate regions were enriched
uniformly across the four multiplexes, showing an average pairwise R2 = 0.936 (Additional file 1: Figure S7).
Thus, our method performs uniformly with respect to
both aggregate metrics of an entire capture as well as
bait-to-bait capture efficiency.
As discussed by Rohland and Reich [16], many capture
methodology papers do not report the number of duplicate reads observed nor specify if duplicate reads are
removed prior to alignment [12-14,17,18] and only report the percentage of their reads that align on or near
target, not directly on target, which may inflate the
amount of usable data. Rohland reports 24% duplicate
reads, and we find a comparable percentage of 14-32%
duplicate reads in our various multiplexes. While our
percentage of on/near target reads is comparable to the
18-55% on/near target reads reported [12-15,17,18],
these numbers may be inflated by the inclusion of duplicates. In our initial multiplexed samples, we find an
average of 81.9% of our reads remaining after aligning
and removing duplicates, and an average of 33.4% of the
remaining bases aligning to our targeted regions. Thus,
approximately 27.4% of our raw data aligns to our
targeted regions in our processed aligned files, yielding an average fold enrichment of 413 (±10.8). Overall, we achieved an average mean target coverage of
(30.43 ± 4.54) when targeting 2.5 Mb with one lane of
sequencing and yielding ~130 million reads. While
within range of prior data, we expected to obtain a
higher on-target percentage. The most obvious reason
for this seemed to be our modified adapter blocking
strategy allowing daisy-chaining, but could also be due
to limitations in oligonucleotide hybridization efficiency
either through non-specific hybridization to non-target
genomic regions or because early versions of Agilent
SureSelect custom captures did not incorporate “bait
boosting”, which calibrates the relative amount of bait
sequences to normalize the expected binding efficiency
to each target. While we could not alter the baits
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Table 1 Comparing sensitivity and specificity to coverage achieved for three sets of multiplexes
≤5% MAF

All allele frequencies
Size
Multiplex

22-24

48

30-32

Coverage

Percent
of Bases,
average
(SD)

Homozygous
wild type
sites

Heterozygous
sites

Homozygous
variant sites

Sensitivity
average
(SD)

Specificity,
average (SD)

Homozygous
wild-type
sites

Heterozygous
sites

≥3

84.4(1.29)

229483

39100

24855

95.02(1.42)

99.82(0.14)

172205

2057

≥5

84.6(1.75)

221031

37332

23810

96.75(1.23)

99.82(0.14)

166050

1961

≥10

75.0(2.65)

201268

33626

21451

98.22(0.98)

99.86(0.13)

151395

1768

≥15

67.1(3.57)

182332

30279

19510

98.60(0.93)

99.88(0.12)

137327

1579

≥20

59.8(4.51)

163986

27202

17643

98.94(0.83)

99.89(0.12)

123572

1418

≥3

89.0(2.30)

239300

39218

26310

95.80(1.42)

99.90(0.08)

187077

2109

≥5

84.1(3.14)

230685

37434

25232

96.43(0.95)

99.91(0.08)

179900

1997

≥10

74.8(4.54)

209960

33448

22739

98.96(0.51)

99.94(0.07)

163128

1805

≥15

67.1(5.79)

190652

30010

20491

99.33(0.42)

99.95(0.07)

147843

1630

≥20

60.3(6.98)

172373

26937

18505

99.60(0.37)

99.96(0.06)

133259

1449

≥3

89.2(2.55)

245952

40732

26487

96.52(1.08)

99.97(0.03)

184498

1903

≥5

84.4(3.49)

235796

38696

25251

98.23(0.69)

99.97(0.03)

177279

1809

≥10

74.8(5.35)

212716

34440

22505

99.43(0.40)

99.97(0.03)

160352

1600

≥15

66.8(7.25)

192642

30957

20272

99.80(0.19)

99.98(0.03)

145504

1403

≥20

59.5(9.08)

173212

27775

18237

99.90(0.15)

99.98(0.03)

130959

1260

The percent of bases in the targeted intervals that reached the specified coverage threshold is listed. Homozygous wild type, heterozygous, and homozygous
variant sites surveyed indicates the number of each of those positions as seen by the Illumina Omni 2.5-8 array that were used to determine sensitivity and
specificity. Sensitivity is the percentage of heterozygous and homozygous variant sites correctly called heterozygous and homozygous variant, respectively.
Specificity is the percentage of homozygous wild type sites called as homozygous wild type. For “All allele frequencies” these values were averaged among all
non-excluded samples. For ≤5%, 2% and 0.5% minor allele frequencies, these values were determined from the cumulative metrics of all non-excluded samples at
sites with 9 or fewer, 4 or fewer, or 1 variant allele in the entire pool, respectively.

within our capture set, we did improve our blocking
strategy by incorporating 1 μL of the Illumina PE 1.0
post-hybridization PCR primer sequence (Additional
file 1: Table S5, the longer oligonucleotide listed under
“Post-Hybridization PCR primers”). This step improved
our average on-target percentage to >70% over our
next 18 multiplexed libraries (data not shown), which
is comparable to the 79% on/near target reads using a
shortened adapter strategy published by Rohland [16].
Analysis of the data from the lane with two 48individual multiplexes (Additional file 1: Table S1, rows
14–15) found very similar results for what we observed
from multiplexes of 22–24 with respect to the percent of
raw reads with an identifiable index, the percentage of
aligned data per person, and the uniformity of data between individuals and between captures (Additional file
1: Figure S5, black symbols). This experiment showed a
higher fold enrichment of 466 (±17.2) with 31.6% (±1.5)
PCR duplication (Additional file 1: Figure S8, red symbols). After removing these duplicates, our on/near-target percentage improved to 47.2% (±1.4) and 37.7%
(±1.39) were directly on targeted regions (Additional file
1: Figure S8, blue and green symbols respectively). We
attribute the higher PCR duplication rate in the multiplexes of 48 individuals over the multiplex of 22–24

individuals to the fact that we have reduced the library
complexity through two mechanisms. First, we only
pooled 35 ng of pre-hybridization capture DNA per individual instead of 50 ng as done with the multiplexes of
22–24, which would result in a lesser amount of unique
DNA fragments available for the post-adapter ligation
enrichment PCR. Second, with 48 individuals pooled for
a single bait set, there is approximately half as much
DNA selected per individual as for captures with 22–24
individuals pooled. Thus, with similar overall read
counts per person, we would expect to see a greater
number of PCR duplicates as a result.
As there were over 4,000 overlapping positions between the Omni 2.5-8 array and our targeted regions,
we used these validated positions to accurately assess
our sensitivity and specificity at various coverage thresholds. Table 1 shows sensitivity, specificity, and coverage
metrics for the custom multiplexes at different MAF
thresholds. As expected, sensitivity is a function of
coverage, starting at >95% with >3-fold coverage for
common variants and improving to 100% with >20-fold
coverage for rare variants (Table 1 and Figure 3). Specificity was consistently ≥99.8% and hardly impacted by
coverage regardless of MAF, confirming that our method
does not systematically introduce false positives (Table 1
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Table 1 Comparing sensitivity and specificity to coverage achieved for three sets of multiplexes (Continued)
≤5% MAF
Size
Multiplex

22-24

48

30-32

2% MAF(4 alleles in pool)

0.5% MAF(1 allele in pool)

Homozygous
variant sites

Sensitivity
(avg)

Specificity
(avg)

Heterozygous
sites

Sensitivity
(avg)

Specificity
(avg)

Heterozygous
sites

Sensitivity
(avg)

Specificity
(avg)

20

92.49

99.98

656

91.6

99.98

127

88.3

99.99

19

95.30

99.98

624

94.9

99.99

119

90.2

99.99

17

97.42

99.98

563

96.6

99.99

111

93.8

100

17

98.50

99.98

507

98.0

99.99

100

96.0

100

14

98.81

99.98

460

98.7

100

90

95.6

100

25

92.97

99.97

651

92.9

99.99

131

94.7

100

25

95.95

99.97

619

95.8

99.99

125

96.8

100

22

98.30

99.97

566

98.4

99.99

111

100

100

19

98.85

99.97

517

99.0

99.99

100

100

100

18

99.05
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Figure 3 Sensitivity as a function of total paired-end read counts at different coverage thresholds for all variants in the sets of
48 multiplexed samples. This graph shows how the sensitivity increases per the number of reads for a given sample with a shallow increase
at 5-fold coverage after a sample reaches 1.8 million reads. Sensitivity is defined as the percentage of heterozygous or homozygous variant
genotypes as seen by the array called correctly as heterozygous or homozygous by sequencing. Red symbols: ≥3x coverage. Green symbols:
≥5x coverage. Blue symbols: ≥10x coverage. Brown symbols: ≥15x coverage. Black symbols: ≥20x coverage. Trend lines were generated using the
“lowess” function in R with default parameters. The sensitivity appears to plateau at around 1.8 million reads, which is prior to excluding duplicate
reads and reads that align off-target. PE = paired-end.
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and Figure 4). For rare variants with ≤2% MAF in this
experiment, we find a sensitivity of 92.9-99.6% and 94.7100% with coverage ranging from ≥3-20-fold for variants
with 2% MAF and 0.5% MAF, respectively (Table 1).
Specificity was ≥99.99% at all coverage levels for either
MAF. These results indicate that allele dropout is not
occurring with our method.
Additional file 1: Figure S9 compares sequencing
coverage from a single individual for all common GWA
positions against all bases in our 2.5 Mb capture with
1.4 M paired-end reads. Once a base position surpasses
3-fold coverage, the representation of GWA positions
versus any base position with similar coverage is approximately equivalent (as are the mean and median
values). These results support using high-density GWA
positions for validation of sequencing results and extrapolating to the entire dataset. We then analyzed our nonarray variant calls from our multiplexes of 48 (Table 1,
rows 14–15) for accuracy. Any variant found in the Exome
Variant Server and not considered a likely false positive
by their Support Vector Machine (SVM) [25] was considered. Of the 10,854 non-SVM, non-GWA variant calls
made, 9,622 are in dbSNP135 (88.65%). This degree of
overlap would not be observed if variants were being
called by random chance.
We have also surveyed all variation in our multiplexes
of 22–24 individuals (Additional file 1: Table S1, rows
7–10) to calculate the Ti:Tv ratio according to the work
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of DePristo [26] (for details see Additional file 1: Results
under “Transition : Transversion (Ti/Tv) ratio analysis”).
We find additional support that we are calling variants
as expected, particularly those positions with ≥15-fold
coverage.
Often, DNA samples are a precious resource, with very
little material in which to conduct large scale genomic
surveys. We have been able to use relatively little source
DNA per person by eliminating all sample transfers
prior to pooling, which is enabled by having SPRI beads
present in solution from the beginning of the protocol.
These beads can stay in place and do not appear to alter
the quality of the library creation reactions. Our strategy
is modified from prior reports by Rohland [16] and
Fisher [19]. Many investigators do not have access to full
automation of the hybridization capture library creation
process. Fisher introduced exclusive bead cleanup for
use with fully automated single exome library creation,
without multiplexing. While results were highly uniform
when employed with full automation, there was a large
dropoff in the percentage and uniformity of captured
bases when bead cleanup was performed manually [see
ref. 19, Additional File 10. Rohland performed sonication
in a 96-well PCR plate without beads present in solution
(unlike us) and also optimized their bead cleanup for
automation. However, as mentioned above, they report a
loss of 50% of source DNA after adapter ligation. We
have exclusively performed manual library preparations

Figure 4 Specificity as a function of total paired-end read counts at different coverage thresholds for the sets of 48 multiplexed
samples. Coverage has little impact on specificity, which starts at ≥99.8% for most individuals with >1.25 million reads. Specificity is defined as
the percentage of homozygous wild type genotypes as seen by the array called correctly as homozygous wild type by sequencing. Red symbols:
≥3x coverage. Green symbols: ≥5x coverage. Blue symbols: ≥10x coverage. Brown symbols: ≥15x coverage. Black symbols: ≥20x coverage. Trend
lines were generated using the “lowess” function in R with default parameters. The dip in specificity at around 2.25 million reads is likely due to
noise as a single extra false positive can cause the observed shift downward. PE = paired-end.
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with multichannel pipettors and observe excellent recovery of source DNA, which is a cost effective and accurate alternative that is accessible to any lab.
We investigated whether issues such as bait GC content or strand bias adversely impacted our results. We
observed a large dropoff in sequencing coverage with
baits that were high in GC content and targets <180 bp
(discussed further in Additional file 1: Figures S10a and
10b), and performed an analysis to characterize whether
strand bias impacted our variant calling (Additional file 1:
Figure S11). From these results, we believe that GC bias
in hybridization efficiency can be mitigated through “bait
boosting” (or designing baits with no more than 35% GC
content) and strand bias did not adversely effected our
results.
However, one serious potential drawback in integrating
large scale indexing would be data contamination due to
index switching, or the transfer of an index from one individual to the sequencing read of another individual.
Unexpectedly, the multiplexes of 22–24 and 48 demonstrated superior specificity for rare variants rather than
common variants, which seems counterintuitive, but is a
consistent finding at all coverage thresholds (Table 1).
To explore this result further, we considered the validated positions binned by the number of variant alleles
at each position called by array genotyping in the entire
pool of 96 captured in two multiplexes of 48 (Additional
file:1 Table S6). The percentage of reads with variant
alleles in individuals who were homozygous wild type at
these positions increases as a function of the frequency
of the variant allele in each bin. This indicated to us that
there was up to 9% of reads with an inappropriate index
in our samples. We use a large excess of adapters to
drive ligation of every possible template strand. We
surmised that a large percentage of our misattributed
indexes were due to an excess of unligated adapters
present in the PCR enrichment, as shown by the bimodal peaks in the green tracing on Additional file 1:
Figure S12 and schematically diagrammed in Additional
file 1: Figure S13. We tested this by adding an additional
bead purification step to remove to remove unligated
adapters from our multiplexes of 30–32 individuals
(Table 1, rows 11–13). We further analyzed variants
with a MAF of ~50% (Additional file 1: Table S6) and see
an equivalent specificity for common and rare variants
with the inclusion of this step (Table 1, rows 11–13). In
addition, the lesser degree of misattributed indexes in
the multiplexes of 30–32 improves sensitivity for common
and rare variants compared to the prior multiplexes. Our
results suggest that index switching is a random and stochastic process resulting in approximately 3.4% of reads
in the entire pool attributed to an incorrect index. We
propose a mechanism for index switching in Additional
file 1: Figure S13. None of the previously mentioned
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reports on multiplexed hybridization capture discuss this
[12-18] which may further skew their findings, but one
possible source of this observation is covered in detail by
Kircher and colleagues [27] as “jumping PCR”. Kircher
reports that over 0.7% of misattributed indexes are
expected when pooling samples prior to PCR for multiplexed capture. If we subtract this source of error from
our result, we are left with 2.64% of reads with an incorrect index (a 3.5-fold improvement from initial experiments). The source of this is unclear, but may be caused
by further residual unligated indexes in our sample prior
to PCR enrichment, a different rate of “jumping PCR”
due to innate differences in polymerases used (Amplitaq
Gold by Kircher vs. the TruSeq kit reagents), or perhaps
erroneous array calls. Thus, while our percentage of incorrectly indexed reads was not as low as reported by
the double indexing strategy of Kircher [27], the amount
we did have did not appear to impact our accuracy for
common or rare variant detection.

Conclusions
The genomic analysis of rare variants in complex disease
will continue to drive pathophysiological research and
clinical questions. Sequencing many individuals at any
number of candidate loci is required to obtain the statistical power necessary for detecting disease-related, rare
functional genetic variants associated with complex phenotypes. As sequencing capacity continues to increase, the
need for additional multiplexing is required to maximize
the efficiency of the sequencing output. Pooling will also
enable sequencing to move more readily into the diagnostic arena as a more cost effective method for screening
multiple genes for rare functional variation. We report a
cost-effective and fully scalable, pre-hybridization multiplexed in-solution capture method, amenable to <100 ng
of input DNA per person due to removal of sample transfers during library preparation enabled by the constant
presence of SPRI beads and resulting in a 50% reduction
in the volume of library preparation reagent necessary.
Sequencing analysis was performed by bioinformatic
pipelines aligning raw data with Novoalign and calling
variants from anonymous pools using SPLINTER or
indexed samples using SAMtools. Both pipelines showed
consistent, coverage-dependent high sensitivity ranging
from 95-99% for substitutions with a dropoff in concordance for detecting INDELs. For rare variants (MAF <2%),
we achieved a sensitivity and specificity of 99.4% and
99.7% for pooled exome analysis and ≥96.6% and
≥99.99%, respectively, for custom capture libraries of
22–48 individuals. While within the range of published
reports, we found our on-target percentage to generally
be in the 40-50% range, but has improved with the
addition of another post-enrichment PCR primer to act
as an additional blocker. Our blocking strategy utilizes
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deoxyinosines to span the novel 7 bp indexes rather
than degenerate nucleotides to reduce the complexity of
the DNA mixture. In our system, we found that optimal
hybridization and sequencing representation occurred
with baits having 25-35% GC content and targets of
>240 bp. We also found no negative impact due to strand
bias. However, one serious drawback to larger multiplexing of indexed samples is index switching leading to the
attribution of variants to the incorrect individual. We
have quantified the prevalence of this phenomenon and
shown it to occur most frequently at wild-type or common variant positions simply due to the abundance of
those reads in the sample. By incorporating an additional
purification step during library preparation to remove excess unligated adapters, this effect can be mitigated. In
sum, cost savings can be realized through the use of less
pre-enrichment library preparation reagents, use of more
standard plasticware for sonication, capturing up to 48
individuals with a single hybridization, multiplexing multiple libraries for sequencing, and the ability to call rare
variants accurately with as little as 5-fold sequencing as a
lower threshold (albeit sensitivity improves with higher
coverage). While there are a variety of reports describing
pooled sequencing or multiplexed solution hybridization
capture [10-18], our method offers a highly uniform, reproducible workflow for smaller labs that may not have
access to high-throughput robotics but still wish to quantify rare variation within specific populations.

Methods
Individual and pooled exome sequencing library
preparation

DNA was isolated from buccal swabs collected from a
nuclear family of five Caucasian individuals (four females
and one male) in accordance with Washington University
Human Research Protection Office protocol #10-0340.
DNA was prepared for sequencing according to the
protocol included with the Illumina Paired-End Sample
Prep Kit (cat# PE-102-001; San Diego, CA). Additional
file 1: Table S1 summarizes the amount of input DNA
used for the individual and pooled exomes along with the
sequencing platform and enrichment kit used. The five
individual samples and the pooled sample then proceeded through each step of the library preparation
protocol as described in the accompanying Agilent
protocol.
Exome enrichment

Exome enrichment from the prepared DNA libraries
was performed using the Agilent (Santa Clara, CA) SureSelect Human All Exon Kit [20] for Illumina Paired-End
Sequencing Library Prep targeting 38 Mb of the human
genome. Hybridization, recovery and enrichment were
done according to protocol version 1.0.1, October 2009
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with no differences from the stated protocol for the single individual samples. For the pooled sample, two parallel hybridizations were performed and then combined
prior to magnetic bead purification in order to optimize
the amount of uniformly hybridized sample available for
downstream reactions.
Individual and pooled exome analysis

Raw sequence data in fastq format was aligned to the
NCBI human genome build 36 (hg18) [28] using a purchased, multi-threading version of Novoalign [29]. Variant calling from the aligned output for the individual
exomes was then performed using SAMtools [23] to manipulate alignments in SAM format and call substitutions
as well as insertions and deletions (INDELs).
Raw sequence data in fastq format was aligned with
Novoalign version 2.05. An alignment threshold of 200
was used (−t 200), with adapter stripping (−a AGATCG
GAAGAGCG) and quality calibration enabled (−k).
Reads with multiple alignments were discarded (−r none,
–e 1) and output was in SAM format (−o SAM). Header
lines were removed and the aligned data was then converted to BAM format with SAMtools “import” and
sorted with SAMtools “sort”. Duplicate reads were then
removed using Picard “MarkDuplicates”. The resulting
file was sorted again and indexed with SAMtools “index”.
Variants were called with the SAMtools version 0.1.18
mpileup command, using options -AB –ugf and bcftools
“view” with settings -bvcg. Variants were filtered with
vcfutils “varFilter” using default settings except retaining
all variants with under 99999 reads.
For the pooled exome sample, the alignment was performed using Novoalign using a reference sequence for
the 165,637 bait intervals from the exome capture plus
76 bp flanking bases. The alignment settings are as
described above with the exception of output “Native”
format instead of SAM format, and the aligned data was
converted to a format consistent with the SPLINTER
aligner output for SNV calling [30]. These modified files
were used as input for variant calling using SPLINTER
[9]. To minimize memory limitations during the variant
calling process the human genome reference sequence
was divided into 166 files with ~1,000 capture baits per
file, each file was run as a separate job and parallelized
one job per available CPU core. The settings for SNV
variant calling using SPLINTER6r were as follows:
24 cycles incorporated, -1.3 p-value cutoff (log10 scale),
using only unique reads, 2 edits (mismatches from reference) allowed, specifying a maximum of 10 alleles in the
pool. Our prior reports on pooled sequencing relied on
internal controls to model sequencing errors and establish a P-value that could be used to calibrate SPLINTER’s
sensitivity and specificity for variant calling. The number
of sequencing cycles to be incorporated was chosen as
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described by Vallania [9] based upon error rates identified in 392 base pairs in the FABP1 gene (exon 3 plus
76 bp flanking sequence) with no called variants on the
arrays or sequencing (Additional file 1: Figure S1). The
model created from this negative control is used by
SPLINTER to optimize specificity by subtracting systematic artifacts.
Pooled sequencing and indexed custom library
preparation

The entire protocol is detailed in the Supplemental
Methods. The number of individuals multiplexed in each
capture reaction and the multiple captures combined for
sequencing within one lane of the Illumina HiSeq 2000
platform are detailed in Additional file 1: Table S1. Customized adapter, blocker, pre- and post-hybridization
PCR amplification primers and all index sequences used
are listed in Additional file 1: Table 5. Briefly, individual
DNA samples were collected following informed consent
by the Long Life Family Study (LLFS) [31]. For custom
hybridization capture of 464 candidate genes thought
to be relevant for extreme longevity (Additional file 1:
Table 4), a bait set was created using the Agilent eArray
online tool [32] for the Agilent SureSelect Custom DNA
Capture [20] using 2X tiling frequency, a exon-centered
layout strategy, and eliminating probes that overlap
standard repeat masked regions by 20 or more bases. Of
the 6,630 targeted intervals, 6,369 were covered by at
least one bait. These intervals were used for calling variants, as sequence in these intervals without baits due
to overlapping standard repeat masked regions could
achieve coverage due to adjacent baits. There were
2,500,709 bases (2.5 Mb) covered by baits in 6,966 distinct intervals, and these bases were used when calculating coverage metrics.
Pooled sequencing data analysis of 92 individuals
at 464 genes

For pooled analysis, all reads from the indexed data set
using captures of 22–24 individuals (Additional file 1:
Table S1, rows 7–10) were considered, and the 7 bp indexes were trimmed from the end of read 1. All analysis
was done using the SPLINTER6t package [33]. Forward
and reverse reads of each pair were trimmed to 80 bp
and analyzed as single reads. Each set of reads (forward
and reverse) was compressed with “RAPGAP_read_
compressor_v2.pl”. A reference sequence was created
in fasta format consisting of the bait-covered intervals
with 101 bp flanking regions joined with the PhiX174
reference sequence [34]. The compressed files were
aligned with “RAPGAPHASH5d” to this reference sequence allowing up to five mismatches. Each aligned
file was tagged with a file-specific identifier using
“RAPGAP_alignment_tagger.pl” and the aligned files
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were concatenated together. An error model was then
generated with “EMGENERATOR4” using the entire
PhiX174 reference sequence, considering only unique
reads, allowing up to five mismatches, and adding
pseudocounts. The number of sequencing cycles to be
incorporated was chosen as described by Vallania [9],
with newer versions of SPLINTER allowing selective
discarding of sequencing cycles with high cumulative
error rates. The error model of the PhiX174 reads
(Additional file 1: Figure S1) shows that cycles 3, 16,
20, 26, 39, 45, 47, 48, 49, 56, 57, 60, and 65 had cumulative error rates >0.02% in one of the two aligned
files and were thus eliminated from variant calling. For
variant calling with SPLINTER6t, the remaining 67 cycles
were considered, up to five mismatches were allowed,
the second order error model created with PhiX174
was utilized, a p-value cutoff of −1.3 (log10 scale) was
used, and the allele count was set at 200. Coverage mode
output was specified to allow coverage of all bases to be
considered regardless of the presence of a variant.
Of the 92 individuals included in this data, 89 were
successfully genotyped by the Illumina Human Omni
2.5-8 Beadchip SNV array. We restricted our comparison between the sequencing and the array by discarding
array-based SNV positions as follows: 1) all alleles from
the 89 successfully genotyped individuals (n = 178) did
not contain a clear call, 2) if the position did not achieve
an average of 20-fold coverage per allele in the sequencing data, 3) if the Illumina genotyping output was ambiguous as to the reference and variant allele, 4) if the
position was a duplicate within the chip, in which case
only one of the duplicate positions was considered. Of
the 4,466 positions that overlapped between the array
and our sequencing targets, 875 pass these filtering criteria. Of these, 376 were called wild type/wild type by
the array in all individuals with no minor allele call by
SPLINTER. The remaining 499 SNV positions (45,908
total) had at least one minor allele called by either the
array or SPLINTER and were used to determine sequencing SNV concordance against the array.
For the 1 bp INDEL analysis, we compared the
SPLINTER calls to an aggregate of the individual
INDEL calls from the indexed analysis. We again
restricted our comparisons to sites with at least 20-fold
average coverage per allele, and additionally we considered only sites that were called as INDELs in the individual analysis.
Pooled indexed custom capture data analysis

Sequencing analysis for indexed captures: Reads are
separated by index, allowing for 1 bp mismatches. Reads
are then aligned to the human genome (hg19/NCBI 37.0)
with Novoalign (V2.07.15) using the parameters
“-r none -e 1 -o softclip -H -k -t 200 -i PE 280 100 -a
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AGATCGGAAGAGCACAC GTCTGAACTCCAGTCA
CAGATCGGAAGAGCGTCGTGTAGGGAAAGATGTA”
and output in SAM format with appropriate read
group, ID, sample, platform, and library tags to conform to SAM specifications. Aligned files in SAM format are converted to compressed BAM format with
SAMtools “view -bSu” and piped into samtools “sort”.
All SAMtools commands were done with samtools0.1.18. Duplicate reads are removed with picard-tools1.58 “MarkDuplicates” using default settings and the
resulting bam file is indexed by SAMtools. Reads are
realigned around candidate INDELs with the Genome
Analysis Toolkit’s (version 1.3-21) “RealignerTargetCreator” and “INDELRealigner” using default settings
other than restricting the realignment to sequence
within 1000 bp of our targeted intervals. Read pair information is fixed with picard-tools-1.58 “FixMateInformation”. This aligned file is indexed with SAMtools to
yield the processed aligned file.
Variants are called using samtools-0.1.18 mpileup.
We specify “-q 5 -Q15 -ABug”, as well as our targeted intervals with 50 bp flanking regions, and pipe
the output into bcftools “view -bvcg”. This intermediate
file is run through bcftools “view -e” and vcfutils
“varFilter -D 1000”. We then change any heterozygous
calls with under 20% of the reads matching the reference
or variant allele to a homozygous variant genotype or
homozygous wild type genotype, respectively.
We use the Novoalign metrics output to determine
the number of reads that align and we use the Picard
“MarkDuplicates” output to determine the percent duplication in our samples. We use the Genome Analysis
Tookit’s version 1.0.2885 “DepthOfCoverage” to determine average coverage over specified intervals and
utilize the histogram output to calculate the percent of
bases reaching various coverage thresholds. We use picard-tools-1.58 “CalculateHSMetrics” to determine the
percent of bases directly on our targeted intervals (on
target), the percent of bases on and within 250 bp of our
targeted intervals (on or near target), the fold enrichment for our captures, and the average coverage
achieved by our captures. We specify for our target
interval file and our base interval file a list of targets that
were directly covered by baits.
Comparison of sequencing calls to array calls: The filtering criteria for choosing positions was identical to the
pooled analysis, with two exceptions: 1) if an INDEL was
called within 15 bp of an array position in at least one
individual, that position was discarded, 2) no default
coverage threshold was considered. In addition, if a SNV
was called within 15 bp of an array position, that position was not considered for that individual. For the
multiplexes of 22–24 individuals, 89 of 92 individuals
had successful genotyping. For the multiplexes of 48
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individuals, 94 of 96 individuals had successful genotyping. For the multiplexes of 30–32 individuals, all
92 individuals had successful genotyping. For each data
set, we consider positions with 9 variant alleles or fewer
as seen by the array to be rare variants. To calculate
sensitivity, we sum the number of positions called heterozygous by the array and heterozygous by sequencing with the number of positions called homozygous
variant by the array and homozygous variant by sequencing. We then divide this sum by the total number of
positions called heterozygous or homozygous variant by
the array. Thus, our sensitivity calculations are predicated on calling genotypes accurately, not solely determining the presence of a variant (i.e. if we call a site
heterozygous and the array indicates it is homozygous
variant, this counts against our sensitivity). To calculate
specificity, we divide the number of positions called
homozygous wild type by the array and homozygous wild
type by sequencing by the total number of positions
called homozygous wild type by the array.
Sequencing

Sequencing was performed in the Center for Genome
Sciences and Systems Biology at Washington University
using either the Illumina Genome Analyzer IIx and
generating 76 bp paired-end reads or the HiSeq 2000
platform generating 101 bp paired-end reads (Additional
file 1: Table S1). Raw sequence data for the exome sequencing is available in dbGaP using accession number
phs000553.v1.p1. GWA and sequencing information
from the 280 LLFS patients is available in dbGaP using
accession number phs000397.v1.p1.
Genome wide microarray

Individuals undergoing exome sequencing were genotyped
by the Affymetrix Genome-wide Human SNV Array 6.0
performed by the Washington University Clinical and
Molecular Cytogenetics Laboratory. These data are accessible at dbGaP accession number phs000553.v1.p1.
Individuals included in the custom pooled and indexed
hybridization capture experiments were genotyped by
the Illumina HumanOmni 2.5-8 Beadchip SNV array
by the John’s Hopkin’s Center for Inherited Disease
Research (CIDR). These data are accessible at dbGaP
accession number phs000397.v1.p1.

Additional file
Additional file 1: Additional Table 1. A summary of the individuals,
multiplexing, DNA input / person, hybridization reagents, sequencing
platform, and use of indexing for the experiments described in this
report. LLFS = Long Life Family Study participants. Additional Table 2.
Individual and pooled exome sequencing metrics. Each of the five
individual exomes was sequenced on 2 separate lanes of the Illumina
Genome Analyzer (IIx) platform. Raw reads were aligned by Novoalign
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against the human NCBI reference sequence hg18 and variants were
called by SAMtools using a ≥5-fold coverage threshold. As shown here,
the amount of raw data and percentage of aligned reads was highly
uniform for each independent sample. The pooled sample was
sequenced on the Illumina HiSeq 2000 platform and aligned using
Novoalign with only the exome reference target sequences with 76 bp
flanks for each target. Given the difference in reference sequence, more
raw data was discarded which artificially reduces the expected foldenrichment. However, as evidenced by the mean target coverage of
1,389-fold (278-fold/person), we had more than ample data for variant
calling at each target sequence. Additional Figure 1. SPLINTER error
models generated in custom pooled sequencing analysis. These graphs
model the percentage of sequencing errors (Y-axis) for each sequencing
cycle (X-axis) for every type of substitution in the forward read (panel A)
and the reverse read (panel B). The black line is the sum of all individual
error rates. Similar plots were generated from 392 non-variant bases in
the FABP1 locus for the pooled exome experiment. Because this error
modeling is done with each experiment, SPLINTER’s accuracy should
remain consistent regardless of the Illumina sequencing platform used. Pr
= probability (e.g. Pr (T∣C) means the probability of seeing an erroneous
T given that the wild type base at that position is a C). Additional
Figure 2. Using the NCBI CCDS exome definitions (http://www.ncbi.nlm.
nih.gov/CCDS/CcdsBrowse.cgi), there are a maximum of 7,087 positions
in common between the Agilent 38 Mb exome and Affymetrix 6.0 GWA.
Due to “no-calls” on either platform, there was an average of 6,725
positions/individual used to calculate sensitivity and specificity.
Sequencing calls were made using a coverage threshold of 5-fold/
chromosome. For pooled exome sequencing, we generated 1.44x109
total paired-end reads, of which 66.82% aligned to the annotated
reference. At 76 bp per read, this equates to an average of 192-fold
coverage of every base in the 38 Mb capture per allele in our 10 allele
pool. Aligned reads in “Native” format from Novoalign were converted to
a format compatible with SPLINTER for SNV calling using a custom Perl
script (found online at http://druleylab.wustl.edu). A) Sensitivity for
individual and pooled exome variant calling as compared to an average
of 2,937 true variant positions detected by Affymetrix 6.0 array. To be
considered accurate, copy number must match (i.e. heterozygous vs.
homozygous) between the array and the sequencing. The average
sensitivity (defined as identifying the same genotype) is 97% for single
exomes and 99.4% for the pooled sample. The pooled sequencing
compares an aggregate of minor allele frequencies from the array data
against the SPLINTER calls for these variants. SPLINTER called 2,937 variant
positions (of 6,725). B) Specificity was determined by comparing the
remaining wild-type array positions, an average of 4,337 for each sample,
to sequencing calls. The average specificity across all five individual
exomes was 99.8%. Specificity for the pooled sample (99.7%) is calculated
by dividing the number of true negative base calls (by array and
sequencing; N = 3,788) by the sum of the number of true negatives and
false positives (wild type by array, but variant by sequencing). Additional
Table 3. Individually genotyped variant positions from pooled exome
sequencing. The asterisk (*) denotes that in this pool of 4 females and 1
male, we assumed nine X-chromosomes and the minor allele frequencies
are rounded accordingly. There were a total of 127 variant positions notincluded on the genome-wide array that were individually validated by
individual genotyping using Sequenom MassArray. Six of these positions
were novel variants not found in dbSNP 132. NC = no call made by the
SPLINTER algorithm. Additional Figure 3. Discordance between single
and pooled exome minor allele frequency estimates is correlated to a
lack of sequencing coverage. The 2,937 variant positions analyzed in
Figure 1 were graphed against the relative coverage per variant position
(vertical axis). The broader base of the plot (dark blue cubes)
demonstrates that outliers are most likely due to a lack of sequencing
coverage in either the individual or pooled sequencing rather than the
introduction of systemic false positive artifacts. Additional Table 4.
Candidate genes chosen for resequencing from the Long Life Family
Study (LLFS). These 464 genes were chosen by LLFS investigators for
resequencing based on published data relevant to the study aims.
Additional Figure 4. Concordance in INDEL identification between
pooled custom capture sequencing analysis by SPLINTER and SAMtools
from the same indexed individuals. Of the 110 INDELS called with ≥20-
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fold coverage in individual analysis, we identified 99 (90%) with SPLINTER.
For rare INDEL calling, 54 of the 110 were found at a frequency of <5%,
and SPLINTER detected 45 (83.3%). Additional Table 5. Blockers for
hybridization. Additional Figure 5. Raw and aligned read uniformity. The
raw and aligned, unique read counts per individual in four hybridizations
of 22–24 individuals (Additional Table 1, rows 7–10) and two
hybridizations of 48 individuals (Additional Table 1, rows 14–15).
Individuals are ranked from lowest total read count to highest total read
count by total reads per person (black and dark blue symbols). Dark and
light blue symbols: the open squares, circles, triangles, and closed circles
indicate the four different captures of 22–24 individuals. Black and gray
symbols: the open squares and circles indicate the two captures of 48
individuals each. The distribution of symbols across each dataset
demonstrates that individual results did not cluster within captures. The
table lists the metrics for each lane of sequencing, the fold difference
between individuals within each lane and the percentage of indexes
identifiable within each raw data set. Additional Figure 6. PCR
duplicates and capture efficiency for multiplexes of 22–24 (Additional
Table 1, rows 7–10). The graph shows the individual percent of: PCR
duplicates (red symbols), aligned data on target (green symbols) and
aligned data on and near targeted intervals (blue symbols). The two
samples with very low read counts are not shown and the rest of the
samples (n=90) are ranked from lowest total read count to highest total
read count. Different shapes and filling indicate the four independent
captures that were combined for sequencing. “On and near target” is
defined as bases that align on or within 250 bp of target intervals after
removing duplicates. “On target” is defined as bases that align directly on
targeted intervals after removing duplicates. The “Individual samples”
numbers correspond to the ones used in Additional Figure 3. Additional
Figure 7. Targeted intervals ranked by coverage achieved between
different samples and captures. One sample from each of the four
multiplexes of 22–24 was chosen for this plot. Observed indexes
ACAGATA, ATCAGCA, TGCTGGG, TTACGAT where chosen, with read
counts ranging from (1,580,586 - 1,599,797). Of the 6,966 distinct targeted
intervals, the 6,604 that achieved greater than 0x average coverage in all
4 of these samples were considered for this plot. All intervals were
ranked by average coverage within each sample with 1 being the
highest and 6,604 being the lowest and plotted. Between all four
samples, the average pairwise R2 = 0.936, showing a high level of
uniformity between captures. To determine if candidate regions were
enriched uniformly across the four multiplexes, we ranked the 6,966
intervals that were covered by baits by coverage in one sample from
each of the four captures. Comparing the ranks of all 6,604 intervals with
over >0X coverage in each of the four samples, the average pairwise R2
= 0.936 (Additional Figure 4). Thus, our method performs uniformly with
respect to both aggregate metrics of an entire capture as well as bait-tobait capture efficiency. Additional Figure 8. PCR duplicates and capture
efficiency for multiplexes of 48 (Additional Table 1, rows 14–15). The
graph shows the individual percent of: PCR duplicates (red symbols),
aligned data on target (green symbols) and aligned data on and near
targeted intervals (blue symbols). The two samples with very low read
counts are not shown and the rest of the samples (n=90) are ranked
from lowest total read count to highest total read count. Different shapes
indicate the two independent captures that were combined for
sequencing. “On and near target” is defined as bases that align on or
within 250 bp of target intervals after removing duplicates. “On target” is
defined as bases that align directly on targeted intervals after removing
duplicates. The “Individual samples” numbers correspond to the ones
used in Additional Figure 3. We see an improvement in overall on/near
target percentage compared to our smaller multiplexing experiments
due to improving our blocking strategy by adding 1 uL of the 58 bp
post-hybridization PCR primer Illumina PE 1.0 (the longer oligo listed
under Post-hybridization PCR primers on Additional Table 5) to the
Hybridization Capture step outlined in the Supplemental Methods.
Additional Figure 9. Comparing genome-wide array position coverage
to sequencing coverage. This plot was generated using the observed
index TAGTATT from the set of 22–24 multiplexed captures, which
achieved 1,404,000 million reads, closest to the average for all 92
samples. Blue circles: percent of targeted bases at specified coverage
threshold. Red circles: percent of array positions at specified coverage
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thresholds. Squares: median coverage achieved when considering only
positions at 3-fold coverage or greater. Triangles: mean coverage
achieved when considering only positions at 3-fold coverage or greater.
The close overlap of the mean and median indicate the array-based
positions accurately reflect the sequencing positions with respect to the
overall coverage achieved. Additional Figure 10A. Coverage achieved
depends on GC content of designed baits. This plot was generated using
the observed index TAGTATT from the set of 22–24 multiplexed captures,
which achieved 1,404,000 million reads, closest to the average for all 92
samples. The average coverage for each bait was plotted against the%
GC content of the bait with the boxplot function in R. Additional Figure
10B. Coverage achieved depends on target interval size. This plot was
also generated using the observed index TAGTATT. The average coverage
for each bait was plotted against the target interval size that the bait
belonged to with the boxplot function in R. Higher coverage in targeted
intervals ≥240 bp was observed relative to 120 bp and 180 bp intervals.
While partially due to having a greater number of bases targeted by two
baits in these intervals due to specifying 2X tiling frequency, we feel this
is more largely a result of flanking sequence from a fragment for one bait
yielding coverage for an adjacent bait. Additional Figure 11. Bioanalyzer
traces of subsequent steps during indexed library preparation. Red line:
individual sonicated and purified sample. Blue line: individual endrepaired and purified sample. Green line: individual adapter ligated and
purified sample. The three different populations beyond 100bp may
indicate fragments with 0, 1, and 2 adapters ligated. The bimodal peaks
<100 bp correspond to unligated adapters. Cyan line: pre-capture,
purified PCR product. Magenta line: post-capture, purified PCR product.
The fact that the majority of our fragment sizes were >200 bp supports
our previous conclusion that our fragments of ≥240 bp demonstrated
higher total coverage due to flanking sequence from one bait
contributing to total coverage for an adjacent bait (see Additional Figure
10B). Additional Figure 12. Strand bias is not adversely affecting
sequencing calls. To explore whether strand bias in sequencing output
was adversely affecting variant calls in the custom capture sequencing
from the multiplexes of 48 individuals (Additional Table 1, rows 14–15),
we summed all variant calls from all 96 individuals and compared the
total number of positions (Y-axis) against the percentage of raw
sequencing reads generated from the forward strand (X-axis). Each
column represents a “bin” of a given number of variants with a given
percentage of raw reads generated from the forward strand. We
performed this comparison for all called variants, known and novel, at all
MAFs (Panel A; n = 148,972), against the gold standard dataset of all
positions called homozygous wild-type by GWA (Panel B; n = 308,842).
The two profiles are very similar and the central peak indicates that the
majority of positions had similar amounts of raw data from each strand,
suggesting that strand bias is not adversely affecting sequencing calls for
all positions not called homozygous wild-type by GWA. Additional
Table 6. The percentage of misattributed indexes is improved by an
additional purification of unligated adapter sequences. To test whether
unligated adapters were the source of misattributed indexes in the
multiplexes of 48 (Additional Table 1, rows 14–15), we implemented an
additional purification with 9.45% PEG and 1.25M NaCl after pooling the
adapter-ligated samples and prior to the subsequent PCR enrichment to
more thoroughly remove any unligated adapters in the multiplexes of
30–32 (Additional Table 1, rows 11–13). We focused on positions with a
MAF around 50% (range 39-59%), which provides more positions to
query (215,580 reads mapped to wild type alleles, 3,828 reads mapped to
variant alleles) where multiple individuals should possess one of three
distinct genotypes (AA, AB, BB). Of the 96 individuals captured in two
multiplexes of 48, 94 had valid array genotyping. All positions with 188
valid allele calls were binned according to the number of GWA-called
variant alleles in the cohort. Of the 92 individuals captured in three
multiplexes of 30–32, all 92 had valid array genotyping. Analysis was
identical to the multiplexes of 48, with two samples excluded due to low
coverage and one sample excluded due to having a very high mismatch
rate, possibly due to genotyping performing poorly or a sample handling
mishap not indicative of the method as a whole. Introducing the extra
purification step improved the percentage of misattributed indexes. With
the additional purification in place, we find an average of 1.8% of variant
reads that are attributed to an individual who was homozygous wild
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type by array. At base positions where no variant alleles were called by
array, 0.13% of reads erroneously contain a sequence variant, likely due to
sequencing error or alignment artifacts. Subtracting this background from
the 1.8% of misattributed indexes at positions with a validated variant in
approximately half of all alleles yields 1.67%. We assume that this index
switching is a random and stochastic process, suggesting that we only
“see” half of reads with an inappropriate index because the other half
would adjoin with a read having a matching genotype (e.g. instead of an
index switching from a wild type read to a variant read, it switches from
a wild type read to another wild type read). Thus, we conclude that with
the additional purification a total of ~3.4% of reads contain misattributed
indexes. Additional Figure 13. Schematic diagram demonstrating how
indexed adapters may become affixed to a different source molecule. A)
Primers, Y-shaped adapter-ligated fragments, and unindexed ligated
adapters are mixed together prior to PCR amplification. B) After
denaturation during the first PCR cycle, the reverse primer sits down on
its complementary site during the annealing step. The non-indexed
strand of the unligated Y-shaped adapter is not shown. C) During the
extension phase of the first PCR cycle, the reverse complement strand of
the template is synthesized. D) After denaturation during the second PCR
cycle, the primers sit down on their complementary site during the
annealing step. Additionally, any unligated adapter can sit down and
serve as a primer. An indexing strand with a different index is shown. E)
During the extension phase of the second PCR cycle, any individualspecific sequencing alterations can be attributed to incorrect indexes. F)
After the second PCR cycle, the strand attributed to the wrong index can
be amplified exponentially. Supplemental Methods. We are starting
with 70-375ng of purified genomic DNA per person in the protocol,
suspended in 15ul of TE. [Note: For multiplexes of 48, we have started
with 350 ng, 280 ng, 210 ng, 140 ng, and 70 ng of DNA/person and
achieved equivalent results in terms of percent duplication, data on
target, coverage achieved, sensitivity, and specificity (data not shown).]
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